Archives: Agenda

• Understanding patient expectations when a treatment shows clear benefit during a trial
• Managing continuation pathways once a study ends and the therapy is not yet commercially available
• Exploring where sponsors, sites, and physicians struggle to align on responsibility and feasibility

• Moving beyond transactional outsourcing toward integrated partnership models​
• Mitigating operational unpredictability with clear governance, escalation,​ and proactive engagement​
• How CROs differentiate through delivery consistency and functional expertise

• Exploring how regulatory and economic shifts disrupt timelines
• Supporting teams to adapt while protecting patient access
• Strengthening readiness for rapid pivots in study delivery

Moderator Revati Tatake, Global Head of Pharma R&A and Competitive Intelligence, GlobalData

• Exploring community-based research solutions — particularly mobile visits — beyond simple procedural support, toward a more holistic, human-centered approach
• Demonstrating how mobile research clinicians deliver far more than sample collection, bringing diverse skilled clinician types directly to patients’ homes and communities to perform complex protocol activities
• Highlighting how expanded clinical capability strengthens trust, enhances patient experience and drives high-quality data collection, reinforcing human presence as a key differentiator in an increasingly technology-driven research environment

• Exploring lessons from shifting between outsourcing models
• Supporting clearer expectations between sponsors and CROs
• Strengthening RBQM alignment across portfolios

• Exploring how internal misalignment delays activation
• Supporting faster cross-functional decision‑making
• Strengthening collaboration with regional partners